[Recalled] Eclipse — If the modification made to a plan affects the planning field's dose contributi… | Health Canada 2005-11-08
This is an official product-safety recall record. Below are the verified details from the issuing authority, in plain language.
Recall details
| Product | Eclipse |
|---|---|
| Category | Medical devices |
| Issuing authority | Health Canada |
| Reference | 21675 |
| Country of notice | Canada |
| Authority classification | Type III |
| Last updated (per notice) | 08 November 2005 |
Why it was recalled
According to the Health Canada notice, the identified hazard is: If the modification made to a plan affects the planning field's dose contribution to the primary reference point the treatment field can change without warning which could result in an overdose.
This recall concerns Medical devices products and was recorded by Health Canada. Recalls in this category are published so that owners, retailers, and importers can identify affected units and act quickly.
What to do if you own this product
Review the official notice to confirm whether your unit is affected.
Read the full official notice →
This page indexes a public government recall notice for reference. We do not sell or verify this product; always confirm the current status on the authority's official site.
- Tools and Hardware Expiry and Shelf Life: A Comprehensive Guide
- Allergy-Free Salad Dressing & Mayo Options: A Guide for Sensitive Eaters
- What is 2-(4-nonylphenoxy)ethanol (CAS 104-35-8)? Safety, Regulation & EU/US/Canada Perspective | ProductGuru
- What is 17-(4-nonylphenoxy)-3,6,9,12,15-pentaoxaheptadecan-1-ol (CAS 34166-38-6)? Safety, Regulation & EU/US/Canada Perspective | ProductGuru
- Mastering Freezer-Safe Packaging: A Comprehensive Guide for Consumers
- Top Organic Energy Drink Brands to Power Your Day Naturally